Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $65.05 USD
Change Today +2.15 / 3.42%
Volume 711.7K
STE On Other Exchanges
Symbol
Exchange
Frankfurt
As of 4:15 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

steris corp (STE) Snapshot

Open
$62.90
Previous Close
$62.90
Day High
$65.10
Day Low
$62.64
52 Week High
04/23/15 - $71.39
52 Week Low
10/15/14 - $52.29
Market Cap
3.9B
Average Volume 10 Days
539.1K
EPS TTM
$2.83
Shares Outstanding
59.9M
EX-Date
08/21/15
P/E TM
23.0x
Dividend
$1.00
Dividend Yield
1.45%
Current Stock Chart for STERIS CORP (STE)

steris corp (STE) Related Businessweek News

No Related Businessweek News Found

steris corp (STE) Details

STERIS Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company’s Healthcare segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers; liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables; surgical and examination lights; equipment management systems; operating room storage cabinets; warming cabinets; scrub sinks; gastrointestinal endoscopy accessories; connectivity solutions; cleaning chemistries and sterility assurance products; and cleansing products, including hard surface disinfectants, and skin care and hand hygiene solutions. This segment also provides maintenance programs and repair services; sterilization and surgical management consulting services; information management and decision support services; and other support services comprising construction and facility planning, engineering support, device testing, customer education, hand hygiene process excellence, asset management/planning, and the sale of replacement parts. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators; sterilizers; washers/disinfectors; and high-purity water equipment, as well as various preventive maintenance programs and repair services. The company’s STERIS Isomedix Services segment provides contract processing services using gamma irradiation and ethylene oxide technologies; laboratory testing services; and microbial reduction services. It sells its products to end users, dealers, and distributors. The company was formerly known as Innovative Medical Technologies and changed its name to STERIS Corporation in 1987. STERIS Corporation was founded in 1985 and is headquartered in Mentor, Ohio.

7,600 Employees
Last Reported Date: 05/27/15
Founded in 1985

steris corp (STE) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $800.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $391.0K
Senior Vice President and Group President of ...
Total Annual Compensation: $401.6K
Senior Vice President and Group President of ...
Total Annual Compensation: $321.3K
Senior Vice President of Infection Prevention...
Total Annual Compensation: $328.4K
Compensation as of Fiscal Year 2015.

steris corp (STE) Key Developments

Steris Corp. Announces Quarterly Dividend, Payable on September 22, 2015

Steris Corp. announced that the company's Board of Directors has authorized a two cent increase in its quarterly dividend to $0.25 per common share, representing the 10th consecutive year of dividend increases. The dividend is payable on September 22, 2015 to shareholders of record at the close of business on August 25, 2015.

STERIS Corporation Reports Earnings Results for the First Quarter Ended June 30, 2015; Reaffirms Earnings Guidance for Fiscal 2016

STERIS Corporation reported earnings results for the first quarter ended June 30, 2015. For the quarter, the company's revenue increased 7% to $439.9 million compared with $412.6 million in the first quarter of fiscal 2015, with growth in Healthcare and Isomedix offset by a decline in Life Sciences. As reported, net income was $24.3 million, or $0.40 per diluted share, compared with net income of $24.5 million, or $0.41 per diluted share in the first quarter of fiscal 2015. Adjusted net income was $37.1 million, or $0.62 per diluted share, compared with adjusted net income for the first quarter of the previous year of $32.0 million, or $0.54 per diluted share. Net cash provided by operations was $41.2 million, compared with $46.4 million in fiscal 2015. The company now anticipates revenue growth of 6-7% for fiscal 2016. Expectations for adjusted earnings per diluted share are unchanged in the range of $3.15 to $3.30 for the full fiscal year. The adjusted effective tax rate is anticipated to be approximately 35%. Fiscal 2016 free cash flow is now anticipated to be approximately $155.0 million, reflecting the recent acquisitions. Capital expenditures are anticipated to be approximately $105.0 million, reflecting the impact of acquisitions, continued expansion within Isomedix, new product development and general maintenance and repair for existing facilities.

Steris Corp. Mulls Acquisitions

Steris Corp. (NYSE:STE) is seeking acquisitions. Steris Corp. said, “Steris Corp. will be pursuing M&A activity and look for tuck-in acquisitions that are complementary to businesses around globe.”

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STE:US $65.05 USD +2.15

STE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Catalent Inc $31.96 USD +0.39
Hill-Rom Holdings Inc $53.29 USD +0.45
Teleflex Inc $133.10 USD +5.28
West Pharmaceutical Services Inc $57.09 USD -0.67
View Industry Companies
 

Industry Analysis

STE

Industry Average

Valuation STE Industry Range
Price/Earnings 28.1x
Price/Sales 2.0x
Price/Book 3.4x
Price/Cash Flow 27.9x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STERIS CORP, please visit www.steris.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.